Literature DB >> 11133376

Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis.

J L Burns1, R L Gibson, S McNamara, D Yim, J Emerson, M Rosenfeld, P Hiatt, K McCoy, R Castile, A L Smith, B W Ramsey.   

Abstract

Pseudomonas aeruginosa lung infection is an important cause of morbidity and mortality in cystic fibrosis (CF). Longitudinal assessment of the phenotypic changes in P. aeruginosa isolated from young children with CF is lacking. This study investigated genotypic and phenotypic changes in P. aeruginosa from oropharynx (OP) and bronchoalveolar lavage fluid (BALF) in a cohort of 40 CF patients during the first 3 years of life; antibody response was also examined. A high degree of genotypic variability was identified, and each patient had unique genotypes. Early isolates had a phenotype distinct from those of usual CF isolates: generally nonmucoid and antibiotic susceptible. Genotype and phenotype correlated between OP and BALF isolates. As determined by culture, 72.5% of patients demonstrated P. aeruginosa during their first 3 years. On the basis of combined culture and serologic results, 97.5% of patients had evidence of infection by age 3 years, which suggests that P. aeruginosa infection occurs early in CF and may be intermittent or undetectable by culture.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11133376     DOI: 10.1086/318075

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  202 in total

1.  CFTR is a pattern recognition molecule that extracts Pseudomonas aeruginosa LPS from the outer membrane into epithelial cells and activates NF-kappa B translocation.

Authors:  Torsten H Schroeder; Martin M Lee; Patrick W Yacono; Carolyn L Cannon; A Alev Gerçeker; David E Golan; Gerald B Pier
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-07       Impact factor: 11.205

2.  Genotypic and phenotypic variation in Pseudomonas aeruginosa reveals signatures of secondary infection and mutator activity in certain cystic fibrosis patients with chronic lung infections.

Authors:  Ashley E Warren; Carla M Boulianne-Larsen; Christine B Chandler; Kami Chiotti; Evgueny Kroll; Scott R Miller; Francois Taddei; Isabelle Sermet-Gaudelus; Agnes Ferroni; Kathleen McInnerney; Michael J Franklin; Frank Rosenzweig
Journal:  Infect Immun       Date:  2011-09-19       Impact factor: 3.441

Review 3.  Laboratory aspects of management of chronic pulmonary infections in patients with cystic fibrosis.

Authors:  Melissa B Miller; Peter H Gilligan
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

4.  Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.

Authors:  Sherie Smith; Valerie Waters; Nikki Jahnke; Felix Ratjen
Journal:  Cochrane Database Syst Rev       Date:  2020-06-10

Review 5.  New insights into the pathogenesis of cystic fibrosis sinusitis.

Authors:  Eugene H Chang
Journal:  Int Forum Allergy Rhinol       Date:  2013-11-26       Impact factor: 3.858

6.  Evidence for diversifying selection at the pyoverdine locus of Pseudomonas aeruginosa.

Authors:  Eric E Smith; Elizabeth H Sims; David H Spencer; Rajinder Kaul; Maynard V Olson
Journal:  J Bacteriol       Date:  2005-03       Impact factor: 3.490

7.  Cross-sectional analysis of clinical and environmental isolates of Pseudomonas aeruginosa: biofilm formation, virulence, and genome diversity.

Authors:  Nathan E Head; Hongwei Yu
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

8.  Proteomic analysis of Pseudomonas aeruginosa grown under magnesium limitation.

Authors:  Tina Guina; Manhong Wu; Samuel I Miller; Samuel O Purvine; Eugene C Yi; Jimmy Eng; David R Goodlett; Ruedi Aebersold; Robert K Ernst; Kimberly A Lee
Journal:  J Am Soc Mass Spectrom       Date:  2003-07       Impact factor: 3.109

9.  Microarray analysis of global gene expression in mucoid Pseudomonas aeruginosa.

Authors:  Aaron M Firoved; Vojo Deretic
Journal:  J Bacteriol       Date:  2003-02       Impact factor: 3.490

10.  Immunoproteomics to examine cystic fibrosis host interactions with extracellular Pseudomonas aeruginosa proteins.

Authors:  Hamish G Upritchard; Stuart J Cordwell; Iain L Lamont
Journal:  Infect Immun       Date:  2008-07-28       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.